Christine
Hegedus
Post-Doctoral
Researcher
Tel:
(530) 752-5109
Fax:
(530) 752-1537
email:
Education
Ph.D., Molecular
Toxicology, University of California, Berkeley
B.A., Molecular
& Cell Biology (Immunology emphasis), University of California,
Berkeley
Research
Awards
Environmental
Mutagen Society Student and New Investigator Travel Award. 37th
Annual Meeting, Vancouver, British Columbia, Canada, September 2006.
Publications
Hegedus CM, Skibola
CF, Bracci P, Holly EA, Smith MT. Screening the human serum proteome
for genotype-phenotype associations: An analysis of the IL-6 -174G>C
polymorphism. Proteomics, Vol. 7(4), 548-57, Feb 2007.
Birkner MD, Hubbard
AE, van der Laan MJ, Skibola CF, Hegedus CM, Smith MT. Issues of
processing and multiple testing of SELDI-TOF MS proteomic data.
Statistical applications in genetics and molecular biology, Vol.
5:Article11. Epub 2006 Apr 21.
Hegedus CM, Gunn
L, Skibola CF, Zhang L, Shiao R, Fu S, Dalmasso EA, Metayer C, Dahl
GV, Buffler PA, and Smith MT. Proteomic analysis of childhood leukemia.
Leukemia, Vol. 19(10), 1713-8, October 2005.
Skibola CF, Holly
EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR, Hegedus C, Smith
MT. Body mass index, leptin and leptin receptor polymorphisms, and
non-hodgkin lymphoma. Cancer Epidemiology Biomarkers & Prevention
Vol. 13, 779-786, May 2004.
Presentations
SELDI-TOF MS
Applications in Molecular Epidemiology. Protein Arrays Conference,
Cambridge Health Institute - Pep Talk Week. San Diego, California,
January 2007. (Invited Presentation).
Applications
in Proteomics. Advances in –Omics Workshop. 37th Annual Meeting,
Vancouver, British Columbia, Canada, September 2006. (Invited Presentation).
Proteomics: A
Tool for Biomarker Discovery. UC Berkeley Superfund Basic Research
Project Annual Meeting. May 2006.
Using Proteomics
to Study Protein Expression and Understand Leukemia. Leukemia and
Lymphoma Society. December 2005.
Abstarcts
Hegedus CM, Skibola
DR, Vermeulen R, Rothman N, Steinmaus C, Smith AH, Moore LE, Smith
MT, Skibola CF. Optimization of Urine for Proteomic Analysis. Superfund
Basic Research Project Annual Meeting. La Jolla, California, December
2006.
Hegedus CM, Skibola
CF, Warner M, Skibola D, Pfeiffer RM, Clark M, Steinmaus C, Smith
AH, Smith MT, Moore LE. Association of Arsenic Exposure with Defensin
Levels in the Urinary Proteome. Environmental Mutagen Society. Vancouver,
British Columbia, Canada, September 2006.
Hegedus CM, Skibola
CF, Smith MT, Bracci PM, Holly EA. The IL-6 G-174C polymorphism
is associated with differences in the human serum proteome. American
Association for Cancer Research. Washington D.C., April 2006.
Moore LE, Skibola
CF, Hegedus CM, Skibola DR, Pfeiffer RM, Warner M, Clark M, Steinmaus
C, Alguacil J, Rothman N, Smith MT, Smith AH. Identification of
Biomarkers of Arsenic Exposure and Metabolism in Urine using SELDI
Technology. American Association for Cancer Research. Washington
D.C., April 2006.
Hegedus C, Gunn
L, Shiao R, Skibola CF, Zhang L, Metayer C, Buffler PA, and Smith
MT. Proteomic Analysis of Childhood Leukemia. American Association
for Cancer Research. Anaheim, CA, March 2005.
Gunn L, Shiao
R, Hegedus C, Skibola CF, and Smith MT. Proteomic Analysis of Childhood
Leukemia Cell Lines. American Association for Cancer Research. Orlando,
FL, March 2004.
Skibola CF, Holly
EA, Forrest MS, Hubbard A, Bracci PM, Skibola DR, Coats A, Hegedus
C, and Smith MT. Body Mass Index and Polymorphisms in the Leptin
and Leptin Receptor Genes are Associated With Risk of Non-Hodgkin’s
Lymphoma. Proceedings of the American Association for Cancer Research
Molecular and Genetic Epidemiology of Cancer Meeting. Waikoloa,
HI, 2003.